Lobby-funded 'studies'

How it works

“A study says” is the most convincing phrase in public debate, and it can be purchased. The buyer does not need to fake data; that is risky and rarely necessary. It is enough to choose the question, the method, the comparison group and the moment of publication, then fund a researcher or an “institute” that needs the money. Ask whether sugar causes heart disease and the answer is complicated. Ask whether fat causes heart disease, fund the people who say yes, and sugar quietly leaves the room.

That is not a hypothetical. In 2016, researchers at the University of California, San Francisco published internal documents in JAMA Internal Medicine showing that in the 1960s the Sugar Research Foundation paid three Harvard scientists (the equivalent of roughly 50,000 dollars today) for a review in the New England Journal of Medicine that downplayed sugar’s role in heart disease and pointed at fat. The funding was not disclosed. The review shaped dietary advice for decades. The tobacco industry ran the master version of the playbook from the 1950s: fund research into “other causes” of cancer, set up institutes, and keep repeating that “the science is not settled”. Millions of its internal documents are public today in UCSF’s Truth Tobacco Industry Documents library. Fossil-fuel companies, chemical makers and others have followed the template, as have “think-tanks” with neutral names and undisclosed donors that supply friendly numbers to any policy fight.

The effect is measurable. A Cochrane review of the evidence (Lundh et al., 2017) found that drug and device studies sponsored by the manufacturer reported favourable results and conclusions more often than independently funded ones, a difference that standard quality checks did not explain. Researchers call it the funding effect. It works without anybody lying.

Example

@FreedomToChooseInstitute, 2d NEW REPORT: the proposed sugar tax would cost 4,000 jobs and have no measurable effect on obesity. Read our independent analysis.

@dani_footnotes, 1d Page 38, in grey: “This study was made possible by the support of the Beverage Association.” Independent of what?

Notice that the report may contain real numbers. Notice also that the funder paid for a study of job losses rather than a study of health, and that the result arrived the week before the vote.

Why it works on you

• Science is a password. “Study”, “institute”, “report”, a chart: the costume of research triggers authority bias, and most of us cannot check the method. The same costume is worn by fake experts.
• Doubt is cheap and sticky. The funder does not need you to believe sugar is healthy; “the experts disagree” is enough to postpone the tax. One contrarian paper creates a “debate” that reporters then feel obliged to cover.
• The numbers look clean. A funded study tends to measure the thing that favours the funder and skip the rest (see misleading charts and cherry-picked statistics).

What to do

When someone cites a study: read sideways before you read the study (see lateral reading). Who published it, who funded them, and who funds the funder? Search the institute’s name together with “funding”. Check whether the paper is peer-reviewed and whether independent research agrees. A single study is a data point, not a verdict; a single funded study is a press release.

When you catch yourself: notice that you are happier to accept a study that confirms what you already think. That is the funder’s bet. Apply the “who paid?” question to the research you like, too.

In a comment section: “paid for by X” is a fact worth stating; “therefore it is a lie” is not. Say “this was funded by the industry it defends, and independent studies found the opposite; here is one”, and let readers weigh it.

Don’t confuse it with

• Disclosed industry funding is not automatically disqualifying: a lot of useful research is industry-funded and openly says so. The trick is hidden funding plus a conclusion tailored to the funder.
• Disagreement between honest studies is normal science, not a manufactured controversy. The tell is who benefits from the controversy continuing.